Testing - Pregnant Women

Similar documents
Dengue. (Also Known as Dengue Fever, Dengue Hemorrhagic Fever, and Breakbone Fever)

Zika virus infection Interim clinical guidance for Primary Care

TO: Physicians, other Healthcare Providers, and Laboratories. Please distribute a copy of this information to each provider in your organization.

Zika Virus Guidance for Medical Providers. Denise Smith, PHN, MPA Director of Disease Control Kern County Public Health Services Department

Zika Virus Update for Emergency Care Providers

Zika: Deet, There It Is. Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS

Hepatitis C January 26, 2018

Zika Virus in the Primary Care Setting

Updates in Infectious Diseases. Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016

An Introduction to Dengue, Zika and Chikungunya Viruses

Zika. Nicole Evert, MS Zoonosis Control Branch Department of State Health Services Austin, Texas

Centers for Disease Control and Prevention Zika Virus in Pregnancy What Midwives Need To Know

Fight the Bite Zika Virus Webinar District of Columbia Department of Health

Public Health Image Library. CDC/ Cynthia Goldsmith. Image #

ZIKA VIRUS OUTBREAK. JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016

Geographic distribution ZIKV

What is Zika virus (Zika)?

ZIKA VIRUS TESTING GUIDANCE, UPDATED 7/20/2016

This memo is intended to provide information to NC clinicians and laboratories regarding diagnosis, management and reporting of Zika virus infection.

Zika Virus Update. Partner Webinar 05/12/2016

Zika Virus. Maternal & Fetal Effects. John P. Elliott, MD Medical Director, Valley Perinatal Services Phoenix, Arizona

What s Lurking out there??????

Zika Virus: The Olympics and Beyond

Zika Virus and Control Efforts in Arizona

Travel: Chikungunya, Zika,.. New worries

The pages that follow contain information critical to protecting the health of your patients and the citizens of Colorado.

ZIKA COLLABORATION MEETING: CLINICAL PERSPECTIVE. Julius L. Tonzel Vector-borne Diseases Epidemiologist Louisiana Office of Public Health

Zika Virus Identifying an Emerging Threat. Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services

What is Zika virus? What are the symptoms and complications of Zika virus infection? Are cases expected in Canada?

A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA

Zika Virus. ZIKA VIRUS & PREGNANCY Stephen Champlin, M.D. FLAVIVIRIDAE VIRUS SPECTRUM. Virus family Flaviviridae

NJDOH Communicable Disease Forum

Zika Pregnancy and Birth Defects Surveillance

Hepatitis C Best Practice Guidelines For Local Health Departments

ZIKA VIRUS. John J. Russell MD May 27, 2016

THE ZIKA VIRUS. August 3, Sonia G. Pandit, MPH MBA Chief Executive Officer The Pandit Group

ZIKA UPDATE NOVEMBER Ministry of Health, Barbados

Zika Preparedness: Lessons for the U.S. Public Health System

Carol M. Smith, M.D., M.P.H. Commissioner of Health and Mental Health Ulster County Department of Health and Mental Health May 20, 2016

Local Health Departments: Preparing for and Preventing Zika. March 23, 2016

ZIKA VIRUS: INFORMATION FOR CLINICIANS

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus assay. September 7, 2016

Module Three About Zika Virus: What is Known and Not Known

AAP ZIKA ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES)

Guidance for Investigation and Management of Zika Virus Infection

Updated Information Zika Virus Testing Guidelines

Outpatient dengue management

3/24/2017. CDC S Response to Zika ZIKA 101. Updated February 2, 2017 INTRODUCTION

22 nd Annual Chicago Infection Control Conference

Hepatitis C: Surveillance, Case Definition, and Investigation

SOP GEN-2016B. Revision/ Review Log Revision Date Approved by Reviewed by Revision Details/ Proposal Notes 04 October 2016

Zika Virus. Frequently Asked Questions: Zika Virus and Pregnancy Version

Zika in Texas. How to Prevent the Spread of the Zika Virus

Zika Virus. Robert Wittler, MD

Zika Virus. Disclosure. Zika Virus 8/26/2016

What You Need to Know ZIKA VIRUS

Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox

Outbreak Investigation Guidance for Vectorborne Diseases

Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox

HEALTH ADVISORY: MEASLES EXPOSURES IN NEW YORK STATE

Presentation Overview

Tribal Vector Borne Disease Meeting Inter Tribal Council of Arizona, Inc. Tribal Epidemiology Center February 13-15, 2018 Chandler, AZ

North Carolina Department of Health and Human Services Division of Public Health

Zika Virus Update. Florida Department of Health (DOH) Mark Lander. June 16, Florida Department of Health in Columbia County

European Centre for Disease Prevention and Control. Zika virus disease

Objectives. Dengue, Chikungunya and Zika Virus Infection: Answers to Common Questions. Case 1. Dengue Introduction 10/15/2018

Zika Virus. Centers for Disease Control and Prevention

EPIDEMIOLOGY SURVEILLANCE REPORT NORTHEAST REGION FALL Namitha Reddy Regional Coordinator North/Central West Region NJDOH/EEOH/CDS

Zika Virus and Prevention in Mississippi

ZIKA VIRUS DISEASE: What every clinician should know

Centers for Disease Control and Prevention Zika Diagnosis: Challenges and Opportunities

Zika Virus: Epidemiology and Preparedness NH Emergency Preparedness Conference June 9, 2016

Zika as a reportable condition Testing approval and result notification Zika pregnancy registry Is there a risk of local transmission?

As suggested by one fellow student, please consider the CDC's "Final Rules for Control of Communicable Diseases: Interstate and Foreign

International Journal of Pharma and Bio Sciences A STUDY OF CLINCAL PROFILE IN DENGUE CASES ABSTRACT

Zika Virus Update March 21, 2018

Hepatitis A Case Investigation and Outbreak Response. Terrie Whitfield LPN Public Health Representative

ZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa

Clinical Policy: Diagnostic Testing for Zika Virus Reference Number: CP.MP.111 Effective Date: 06/16

ZIKA Jordan H. Perlow MD Banner University Medical Center Division of Maternal Fetal Medicine Phoenix Perinatal Asoociates

Everything you ever wanted to know about Zika Virus Disease

Zika Virus What Every Woman Needs to Know

Epidemiology Update Hepatitis A

Questions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection

Zika Virus Dr Conor Doherty

Congenital Zika Virus. Rebecca E. Levorson, MD Pediatric Infectious Diseases Pediatric Specialists of Virginia November 4, 2017

When infections go viral Zika Virus

Chapter 2 Hepatitis B Overview

Updated Interim Guidance for the Diagnosis, Evaluation and Management of Infants with Possible Congenital Zika Virus Infection

ARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, & ZIKA VIRUSES

ARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, AND ZIKA VIRUSES

Zika 101 for Occupational Safety and Health Professionals

Zika Virus Outbreak An Update and Overview of the New York State Response

UPDATE ON ZIKA VIRUS INFECTION

SPECIALIZED FAMILY CARE Provider Training

CDC Responds to ZIKA Zika 101

KEY MESSAGES. There are three phases in dengue infection-febrile phase, critical phase and recovery (reabsorption) phase.

5/4/2018. Describe the public health surveillance system for communicable diseases.

Zika Virus. Public Information Update/phone script. Date: March 28, 2016 Time: 11:00 a.m.

Transcription:

Testing - Pregnant Women 81% of women approved for testing in NJ were pregnant In 2017, nearly 95% of pregnant women tested were asymptomatic

CDC Updated Testing Recommendations for Asymptomatic Pregnant Women Recent exposure ono routine recommendation for testing o Testing can be considered based on patient preferences, clinical judgment, and a balanced assessment of risks and expected outcomes Ongoing exposure o NAT (PCR) testing 3x during pregnancy o Serology no longer recommended

Updated Testing Recommendations for Symptomatic Pregnant Women Testing is recommended as soon as possible and within 12 weeks after onset NAT (PCR) and IgM should be performed concurrently and up to 12 weeks after onset

Additional Updates Criteria for evaluating travel exposure for asymptomatic pregnant women = all areas with any risk of Zika transmission Interpretation of lab test results o Take PCR (serum and urine) and serological testing together o Discordant PCR (serum / urine) with negative IgM may require second specimen o Serology timing of infection can not be determined

CDC COCA call today 2pm: https://emergency.cdc. gov/coca/calls/2017/cal linfo_072717.asp https://www.cdc.gov/zika/pdfs/when-to-test-zika.pdf

Zika Testing Approval Rules of Thumb Specimen collection must be within 12 weeks of last exposure (travel or unprotected sexual) o Applies to everyone requesting Zika testing Symptomatic o Onset symptoms within 2 weeks of last exposure AND o Specimens collected within 12 weeks

Testing Approval Rules of Thumb Sexual exposure = unprotected sexual contact with a partner who had a Zika exposure o For men, semen is potentially infectious for 6 months o If a male partner returned from the DR on Jan 1st, the semen would be considered potentially infectious through June 30 th Need dates & location of the sexual partner s travel Need first & last dates of unprotected sexual contact If location and dates are not in CDRSS and SRD-1 form, the specimen may be rejected

Example: John traveled to the DR 1/15-1/30 with his pregnant wife Jane. Jane developed fever & rash on 5/29 6/1 Jane s OB requests Zika testing Travel > 12 weeks. Jane reports ongoing unprotected sexual contact POLL Unprotected sexual contact with John from 1/15 5/25 John s semen would be considered potentially infectious through 7/30 POLL Jane had sexual contact on 5/25 = sexual exposure; symptom onset (5/29) is <2 wks from last sexual exposure (5/25) and date of test request (6/1) is < 12 wks from last sexual exposure - testing is approved

Zika Case Investigation Select a subgroup! o Zika virus disease, congenital; Zika virus infection, congenital; Zika virus disease, non-congenital; Zika virus infection, non-congenital o Signs/symptoms and risk factors are tailored to subgroup Rationale for timely investigation o Identify source of exposure o Determine pregnancy status enroll into US Zika Pregnancy Registry o Provide patient education

Zika Case Investigation Zika Patient Information Worksheet contains most information needed Patient interview needed o Patient education: Prevent mosquito bites for 3 weeks after return from travel Protect against sexual transmission particularly during pregnancy o Ask if household members are ill with Zika symptoms Determine travel/sexual exposure history Refer to healthcare provider for Zika testing If no travel/sexual exposure identified, notify CDS o Re-interview patient 14-21 days after symptom onset (or return from travel) to confirm status of household members

Dates are important Travel enter country in attribute field and 2 dates Relocation to US enter country in attribute field and an arrival date only Sexual exposure o Select Sexual Transmission dates of first/last unprotected sexual contact ongoing can t be used to determine testing eligibility ask physician/patient to estimate date if needed o Also select Sexual Partner s Travel enter country and dates of partner travel Pregnancy CDRSS Risk Factors o Enter pregnancy status on Clinical Info Tab with EDD and current pregnancy ALSO select Exposed during Pregnancy risk factor

Additional CDC Indicators Date the LHD initiated the case investigation Date control measures were implemented and a description, for example: o Spoke with/ faxed healthcare provider to request that they inform patient to: 1) avoid getting mosquito bites for 3 weeks following return from travel; 2) take steps to reduce mosquitos in and around their home; 3) if pregnant and partner traveled to an area with known Zika transmission, to use condoms for the duration of pregnancy Include in case comments

Zika Resources NJDOH Zika Testing Guidelines and Algorithm Zika Patient Information Worksheet NJDOH Delivery Packet Track when You re Back patient education flyer Communicable Disease Investigation Chapter! http://www.nj.gov/health/cd/topics/zika.shtml

DENGUE

New Dengue Subgroups Dengue: fever AND 1 of the following: o nausea/vomiting, rash, tourniquet test positive, aches and pains, leukopenia, or any warning sign for severe dengue (persistent vomiting, abdominal pain, extravascular fluid accumulation, mucosal bleeding, liver enlargement, or increasing hematocrit concurrent with a rapid decrease in platelet count Dengue-like illness: fever Severe dengue: dengue with 1 of the following: o hypovolemic shock caused by serious plasma leakage, severe bleeding, severe organ involvement (including elevated liver enzymes, impaired level of consciousness)

New Possible Dengue Case Status CONFIRMED and PROBABLE cases meet clinical criteria for a subgroup and have acceptable lab results POSSIBLE cases meet the clinical criteria for a subgroup and have a epidemiologic linkage (travel, close contact), but do not have acceptable laboratory results Updated Investigation Chapter and Worksheet: http://www.nj.gov/health/cd/topics/dengue.shtml

Positive Zika IgM results are sent for PRNT o Neutralizing antibodies for both Zika and dengue Positive PRNT results for dengue create a dengue case in CDRSS o If confirmed/probable Zika case dengue will be closed as Not a Case o If not Zika case Dengue and Zika If clinical criteria is met for a dengue subgroup classified as POSSIBLE If asymptomatic, classified as NAC Note: POSSIBLE = SUSPECT cases and are not reported to CDC